Across TCGA pan-cancer cohorts, DDX39AP1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of DDX39AP1’s most consistent transcriptional readouts.
The strongest signal is observed in esophageal carcinoma (ESCA), where DDX39AP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DDX39AP1 is over-expressed in tumor.
ESCA and LUAD are the cancer types where DDX39AP1 tumor–normal differential expression is most reproducible.